Brief: Aspire Biopharma Says Resale Of Up To 159.1 Mln Shares Of Common Stock Underlying Series A Convertible Preferred Stock
17/02/2026 21:43
Feb 17 (Reuters) - Aspire Biopharma Holdings Inc ASBP.O: ASPIRE BIOPHARMA HOLDINGS INC: RESALE OF UP TO 159,090,906 SHARES OF COMMON STOCK UNDERLYING SERIES A CONVERTIBLE PREFERRED STOCK Source text: [ID:n0001493152-26-007123] Further company coverage: ASBP.O ((Reuters.Briefs@thomsonreuters.com;))